ETFs CSPC Pharmaceutical Group Limited

1093

HK1093012172

Name	YTD change	Weight	AuM
VANGUARD FTSE ALL-WORLD UCITS ETF - USD	+12.27%	-.--%	27,154 M€
NYLI CANDRIAM INTERNATIONAL EQUITY ETF - USD	+9.23%	-.--%	274 M€
WISDOMTREE EMERGING MARKETS HIGH DIVIDEND FUND - USD	+19.80%	-.--%	4,070 M€
STATE STREET SPDR S&P EMERGING MARKETS CARBON AWARE ETF - AUD	-0.24%	-.--%	21 M€
CI GROWTH ASSET ALLOCATION ETF -CAD	+10.93%	-.--%	67 M€
UBS MSCI ACWI CLIMATE PARIS ALIGNED UCITS ETF ACC - USD	+12.43%	-.--%	122 M€
STATE STREET SPDR MSCI EMERGING MARKETS FOSSIL FUEL RESERVES FREE ETF - USD	+26.39%	-.--%	182 M€
STATE STREET SPDR S&P GLOBAL DIVIDEND FUND - AUD	-1.70%	-.--%	283 M€
AMPLIFY WEIGHT LOSS DRUG & TREATMENT ETF - USD	+1.86%	4.14%	5 M€
FIRST TRUST S&P INTERNATIONAL DIVIDEND ARISTOCRATS ETF - USD	+10.02%	3.2%	169 M€
ROUNDHILL GLP-1 & WEIGHT LOSS ETF - USD	-8.67%	2.29%	65 M€
L&G ASIA PACIFIC EX JAPAN ESG PARIS ALIGNED UCITS ETF - USD	+6.98%	1.68%	124 M€
LUNATE S&P CHINA HK SHARIAH ETF INCOME - HKD	-22.15%	1.51%	5 M€
STATE STREET SPDR S&P PAN ASIA DIVIDEND ARISTOCRATS UCITS ETF - USD	+7.96%	1.32%	249 M€
CAMBRIA EMERGING SHAREHOLDER YIELD ETF - USD	+26.04%	1.16%	886 M€
STATE STREET SPDR S&P EMERGING MARKETS DIVIDEND ARISTOCRATS UCITS ETF - DIS - USD	+6.09%	1.02%	272 M€
AMUNDI MSCI CHINA ESG SELECTION EXTRA UCITS ETF DIST - EUR	-.--%	0.86%	111 M€
AMUNDI MSCI CHINA ESG SELECTION EXTRA UCITS ETF ACC - EUR	-10.86%	0.86%	511 M€
AMUNDI MSCI CHINA ESG SELECTION - UCITS ETF DR (C) - USD	-13.05%	0.75%	251 M€
FRANKLIN EMERGING MARKETS UCITS ETF - USD	+16.24%	0.63%	89 M€
AMUNDI MSCI EM ASIA SRI CLIMATE PARIS ALIGNED - UCITS ETF DR (D) - USD	+24.80%	0.59%	153 M€
BMO MSCI CHINA SELECTION EQUITY INDEX ETF - CAD	-11.29%	0.58%	85 M€
ISHARES DOW JONES CHINA OFFSHORE 50 UCITS ETF (DE) - USD	-10.15%	0.57%	50 M€
AMUNDI MSCI EMERGING MARKETS SRI CLIMATE PARIS ALIGNED - UCITS ETF DR (D) - GBP	+20.35%	0.54%	27 M€
UBS MSCI CHINA UNIVERSAL UCITS ETF A-DIS - USD	-6.74%	0.47%	244 M€
AMUNDI MSCI EMERGING MARKETS SRI CLIMATE PARIS ALIGNED - UCITS ETF DR (D) - USD	+22.13%	0.47%	174 M€
AMUNDI MSCI EMERGING MARKETS SRI CLIMATE PARIS ALIGNED - UCITS ETF DR (C) - USD	+21.57%	0.47%	2,223 M€
FIDELITY EMERGING MARKETS QUALITY INCOME UCITS ETF - C - USD	+40.86%	0.45%	47 M€
FIDELITY EMERGING MARKETS QUALITY INCOME UCITS ETF INC - USD	+36.28%	0.45%	172 M€
DEKA MSCI CHINA EX A SHARES UCITS ETF - HKD	-13.38%	0.43%	89 M€
L&G ASIA PACIFIC EX JAPAN UCITS ETF - ACC - USD	+11.77%	0.43%	792 M€
ISHARES MSCI CHINA ETF - USD	-12.40%	0.4%	6,244 M€
PIMCO RAFI DYNAMIC MULTI-FACTOR EMERGING MARKETS EQUITY ETF - USD	+24.27%	0.39%	156 M€
ISHARES MSCI EM SRI UCITS ETF - USD	+19.88%	0.37%	3,246 M€

CSPC Pharmaceutical Group Ltd is a company primarily engaged in the production and sales of pharmaceuticals. The Company's main businesses include finished drug manufacturing, bulk product business, functional food and other businesses. The Company's products mainly cover the nervous system, anti-tumor, anti-infective, cardiovascular, respiratory system, digestive and metabolic, and other therapeutic areas. The Company conducts its businesses in domestic and overseas markets.

Employees

18,626

Sector

Pharmaceuticals

Calendar

10-20 Ex-dividend date - 0.18 HKD

More about the company

Income Statement and Estimates

More financial data

Market Closed - Hong Kong S.E. 09:08:14 25/09/2026 BST			5-day change	1st Jan Change
9.330 ^HKD	-0.11%		+4.48%	+10.68%

09-24	CSPC Pharmaceutical Group Limited Initiates Phase III Clinical Trial Of Docetaxel For Injection (Albumin-Bound) For Treatment Of Advanced Breast Cancer In China	CI
09-24	CSPC Pharmaceutical Group Limited Announces Phase III Clinical Trial Of Becotatug In Combination With Osimertinib Achieves Positive Topline Results	CI

ETFs CSPC Pharmaceutical Group Limited

Stocks

1093

HK1093012172

Pharmaceuticals

ETFs positioned on CSPC Pharmaceutical Group Limited

Company Profile

Income Statement and Estimates